INTRODUCTION: We sought to assess the long-term results of conservative treatment for upper urinary tract carcinoma (UUTC) with regard to tumour recurrence and preservation of renal unit. METHODS: From October 1987 to January 2014, 65 patients (median age 68 years) were diagnosed with UUTC and underwent endoscopic and open surgical techniques. Thirteen patients had bilateral disease and one had a single kidney. The primary approach was endoscopic in 37 reno-ureteral units (20 percutaneous resections, 17 ureteroscopies ). Open surgery was performed in 19 cases. A total of 20 patients received mitomycin C. RESULTS: Superficial stage pTa or T1 was noted in 37 patients, infiltrating stage pT2 and pT3 in seven and inverted papilloma in one. The stage of the tumour was impossible to classify in 20. With a median followup of 75.12 months (interquartile range [IQR] 144.71-17.41), the kidney preservation, recurrence, specific survival, and global survival rates were 78.5% (51/65), 40.0% (26/65), 92.3% (60/65), and 69.2% (45/65), respectively. From the patients who had recurrence, 15 were salvaged with radical nephroureterectomy (RNU). The bladder tumour recurrence rate after the surgery was 30.76% (20/65). At the end of the followup, five patients had died of UUTC progression and 16 from other causes. Postoperative complications included one case of fistula, one case of stricture, and one case of nephrectomy due to bleeding. CONCLUSIONS: In selected cases, conservative management is a safe and feasible alternative to RNU, with the advantage of renal unit preservation.
INTRODUCTION: We sought to assess the long-term results of conservative treatment for upper urinary tract carcinoma (UUTC) with regard to tumour recurrence and preservation of renal unit. METHODS: From October 1987 to January 2014, 65 patients (median age 68 years) were diagnosed with UUTC and underwent endoscopic and open surgical techniques. Thirteen patients had bilateral disease and one had a single kidney. The primary approach was endoscopic in 37 reno-ureteral units (20 percutaneous resections, 17 ureteroscopies ). Open surgery was performed in 19 cases. A total of 20 patients received mitomycin C. RESULTS: Superficial stage pTa or T1 was noted in 37 patients, infiltrating stage pT2 and pT3 in seven and inverted papilloma in one. The stage of the tumour was impossible to classify in 20. With a median followup of 75.12 months (interquartile range [IQR] 144.71-17.41), the kidney preservation, recurrence, specific survival, and global survival rates were 78.5% (51/65), 40.0% (26/65), 92.3% (60/65), and 69.2% (45/65), respectively. From the patients who had recurrence, 15 were salvaged with radical nephroureterectomy (RNU). The bladder tumour recurrence rate after the surgery was 30.76% (20/65). At the end of the followup, five patients had died of UUTC progression and 16 from other causes. Postoperative complications included one case of fistula, one case of stricture, and one case of nephrectomy due to bleeding. CONCLUSIONS: In selected cases, conservative management is a safe and feasible alternative to RNU, with the advantage of renal unit preservation.
Authors: Claudio Jeldres; Giovanni Lughezzani; Maxine Sun; Hendrik Isbarn; Shahrokh F Shariat; Lars Budaus; Jean-Baptiste Lattouf; Hugues Widmer; Markus Graefen; Francesco Montorsi; Paul Perrotte; Pierre I Karakiewicz Journal: J Urol Date: 2010-02-19 Impact factor: 7.450
Authors: Mark L Cutress; Grant D Stewart; Edward C G Tudor; Eric A Egong; Simon Wells-Cole; Simon Phipps; Ben G Thomas; Antony C P Riddick; S Alan McNeill; David A Tolley Journal: J Urol Date: 2012-12-07 Impact factor: 7.450
Authors: Thomas Seisen; Benoit Peyronnet; Jose Luis Dominguez-Escrig; Harman M Bruins; Cathy Yuhong Yuan; Marko Babjuk; Andreas Böhle; Maximilian Burger; Eva M Compérat; Nigel C Cowan; Eero Kaasinen; Joan Palou; Bas W G van Rhijn; Richard J Sylvester; Richard Zigeuner; Shahrokh F Shariat; Morgan Rouprêt Journal: Eur Urol Date: 2016-07-28 Impact factor: 20.096
Authors: Pierre Colin; Adil Ouzzane; Géraldine Pignot; Emmanuel Ravier; Sébastien Crouzet; Mehdi M Ariane; Marie Audouin; Yann Neuzillet; Baptiste Albouy; Sophie Hurel; Fabien Saint; Julien Guillotreau; Laurent Guy; Pierre Bigot; Alexandre De La Taille; Frédéric Arroua; Charles Marchand; Alexandre Matte; Pierre O Fais; Morgan Rouprêt Journal: BJU Int Date: 2012-03-06 Impact factor: 5.588
Authors: Morgan Rouprêt; Marko Babjuk; Eva Compérat; Richard Zigeuner; Richard Sylvester; Max Burger; Nigel Cowan; Andreas Böhle; Bas W G Van Rhijn; Eero Kaasinen; Joan Palou; Shahrokh F Shariat Journal: Eur Urol Date: 2013-03-19 Impact factor: 20.096
Authors: Matthew G Kaag; Rebecca L O'Malley; Padraic O'Malley; Guilherme Godoy; Mang Chen; Marc C Smaldone; Ronald L Hrebinko; Jay D Raman; Bernard Bochner; Guido Dalbagni; Michael D Stifelman; Samir S Taneja; William C Huang Journal: Eur Urol Date: 2010-06-25 Impact factor: 20.096
Authors: Mark L Cutress; Grant D Stewart; Simon Wells-Cole; Simon Phipps; Ben G Thomas; David A Tolley Journal: BJU Int Date: 2012-05-07 Impact factor: 5.588